全文获取类型
收费全文 | 10169篇 |
免费 | 659篇 |
国内免费 | 33篇 |
学科分类
医药卫生 | 10861篇 |
出版年
2023年 | 65篇 |
2021年 | 164篇 |
2020年 | 152篇 |
2019年 | 206篇 |
2018年 | 221篇 |
2017年 | 179篇 |
2016年 | 193篇 |
2015年 | 168篇 |
2014年 | 282篇 |
2013年 | 437篇 |
2012年 | 531篇 |
2011年 | 557篇 |
2010年 | 290篇 |
2009年 | 288篇 |
2008年 | 504篇 |
2007年 | 452篇 |
2006年 | 471篇 |
2005年 | 443篇 |
2004年 | 400篇 |
2003年 | 337篇 |
2002年 | 360篇 |
2001年 | 262篇 |
2000年 | 283篇 |
1999年 | 261篇 |
1998年 | 94篇 |
1997年 | 106篇 |
1996年 | 60篇 |
1995年 | 89篇 |
1994年 | 73篇 |
1993年 | 72篇 |
1992年 | 189篇 |
1991年 | 208篇 |
1990年 | 190篇 |
1989年 | 183篇 |
1988年 | 183篇 |
1987年 | 190篇 |
1986年 | 185篇 |
1985年 | 177篇 |
1984年 | 106篇 |
1983年 | 118篇 |
1982年 | 82篇 |
1981年 | 78篇 |
1980年 | 61篇 |
1979年 | 109篇 |
1978年 | 92篇 |
1977年 | 82篇 |
1976年 | 56篇 |
1975年 | 58篇 |
1974年 | 58篇 |
1973年 | 53篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Arvid Nikolai Kildahl Sissel Berge Helverschou Trine Lise Bakken Hanne Weie Oddli 《Journal of mental health research in intellectual disabilities》2020,13(3):201-230
ABSTRACT
Introduction
Individuals with autism spectrum disorder (ASD) and intellectual disability (ID) seem to be at increased risk for post-traumatic stress disorder (PTSD), but knowledge is sparse regarding its identification in this population. Previous research indicates that certain symptoms of PTSD may be more easily recognized, and that identifying reexperiencing and avoidance is particularly challenging. 相似文献2.
3.
4.
5.
6.
7.
8.
Marie Warrer Petersen Tine Sylvest Meyhoff Marie Helleberg Maj-Brit Nørregaard Kjær Anders Granholm Carl Johan Steensen Hjortsø Thomas Steen Jensen Morten Hylander Møller Peter Buhl Hjortrup Mik Wetterslev Gitte Kingo Vesterlund Lene Russell Vibeke Lind Jørgensen Klaus Tjelle Thomas Benfield Charlotte Suppli Ulrik Anne Sofie Andreasen Thomas Mohr Morten H. Bestle Lone Musaeus Poulsen Mette Friberg Hitz Thomas Hildebrandt Lene Surland Knudsen Anders Møller Christoffer Grant Sølling Anne Craveiro Brøchner Bodil Steen Rasmussen Henrik Nielsen Steffen Christensen Thomas Strøm Maria Cronhjort Rebecka Rubenson Wahlin Stephan Jakob Luca Cioccari Balasubramanian Venkatesh Naomi Hammond Vivekanand Jha Sheila Nainan Myatra Christian Gluud Theis Lange Anders Perner 《Acta anaesthesiologica Scandinavica》2020,64(9):1365-1375
Introduction
Severe acute respiratory syndrome coronavirus-2 has caused a pandemic of coronavirus disease (COVID-19) with many patients developing hypoxic respiratory failure. Corticosteroids reduce the time on mechanical ventilation, length of stay in the intensive care unit and potentially also mortality in similar patient populations. However, corticosteroids have undesirable effects, including longer time to viral clearance. Clinical equipoise on the use of corticosteroids for COVID-19 exists.Methods
The COVID STEROID trial is an international, randomised, stratified, blinded clinical trial. We will allocate 1000 adult patients with COVID-19 receiving ≥10 L/min of oxygen or on mechanical ventilation to intravenous hydrocortisone 200 mg daily vs placebo (0.9% saline) for 7 days. The primary outcome is days alive without life support (ie mechanical ventilation, circulatory support, and renal replacement therapy) at day 28. Secondary outcomes are serious adverse reactions at day 14; days alive without life support at day 90; days alive and out of hospital at day 90; all-cause mortality at day 28, day 90, and 1 year; and health-related quality of life at 1 year. We will conduct the statistical analyses according to this protocol, including interim analyses for every 250 patients followed for 28 days. The primary outcome will be compared using the Kryger Jensen and Lange test in the intention to treat population and reported as differences in means and medians with 95% confidence intervals.Discussion
The COVID STEROID trial will provide important evidence to guide the use of corticosteroids in COVID-19 and severe hypoxia.9.
Timothee Dub Bolette Sborg Peter Henrik Andersen Thorolfur Gudnason Hanne Nkleby Ann Lindstrand Rose-Marie Carlsson Hanna Nohynek 《Euro surveillance : bulletin européen sur les maladies transmissibles = European communicable disease bulletin》2021,26(4)
Healthcare workers (HCWs) are at increased risk of both exposure and transmission of infectious disease. Two European Union (EU) directives state that health services are responsible for assessing their employees’ potential exposure to infectious diseases and offering immunisation free of charge. We assessed current policy for immunisation of HCWs and the availability of vaccine coverage data in the Nordic countries by surveying national vaccination experts in Denmark, Finland, Iceland, Norway and Sweden, as well as Swedish county medical officers (CMOs). All national experts and 17 of 21 Swedish CMOs responded. All EU countries had transposed the European directives into national law, while Norway and Iceland had similar national legislation. Recommendations or guidelines were issued in Denmark, Finland, Iceland, Norway and 15 of 17 responding Swedish counties. The range of diseases covered differed by countries and Swedish counties. HCW vaccine coverage data were not systematically collected; incomplete estimates were only available for Finland and two Swedish counties. In conclusion, recommendations or guidelines exist in the Nordic countries, but their impact cannot be assessed, as vaccine uptake among HCWs is not currently measured. Systematic collection of data is a necessary step towards improving HCW immunisation policy and practice in the Nordic countries. 相似文献
10.
Low myocardial glucose uptake in Turner syndrome is unaffected by growth hormone: a randomized,placebo‐controlled FDG‐PET study 下载免费PDF全文